Togo’s Dogta-Lafiè Hospital adopts new tech for prostate cancer care

Health
Wednesday, 29 October 2025 03:19
Togo’s Dogta-Lafiè Hospital adopts new tech for prostate cancer care

(Togo First) - Dogta-Lafiè Hospital in Lomé has introduced Focal One, a French robotic technology for treating prostate cancer using high-intensity focused ultrasound. Togo thus becomes the first African country to adopt this medical device, designed as a less invasive alternative to traditional surgery and radiotherapy.

The Focal One system precisely targets cancerous tissue without incision or radiation, reducing post-operative risks. According to Professor Kodjo Tengue, a urology specialist at Dogta-Lafiè, “this technology marks a major breakthrough in treating localized cancers by minimizing side effects and speeding up recovery.”

The acquisition aligns with the national strategy to modernize healthcare and strengthen precision medicine. Training and knowledge transfer programs are planned with French partners to ensure local expertise in operating and maintaining the device.

The initiative also supports prevention efforts. Alongside this innovation, the hospital has launched a breast cancer screening center as part of the “Pink October” campaign, aimed at promoting early diagnosis and improving cancer control in Togo, where mortality rates from the disease remain relatively high.

To contact us: c o n t a c t [@] t o g o f i r s t . c o m

Please publish modules in offcanvas position.